Key stats
About Invesco NASDAQ Biotech UCITS ETF
Home page
Inception date
Nov 6, 2014
Structure
Irish VCIC
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
Invesco Investment Management Ltd.
ISIN
IE00BQ70R696
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.98%
Health Technology96.79%
Technology Services1.29%
Commercial Services1.17%
Health Services0.71%
Process Industries0.02%
Bonds, Cash & Other0.02%
Miscellaneous0.02%
Cash0.00%
Stock breakdown by region
North America82.47%
Europe17.05%
Asia0.44%
Oceania0.04%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
SBIO invests in stocks. The fund's major sectors are Health Technology, with 96.79% stocks, and Technology Services, with 1.29% of the basket. The assets are mostly located in the North America region.
SBIO top holdings are Gilead Sciences, Inc. and Amgen Inc., occupying 8.33% and 8.24% of the portfolio correspondingly.
SBIO assets under management is 230.88 M EUR. It's risen 4.67% over the last month.
SBIO fund flows account for −53.44 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, SBIO doesn't pay dividends to its holders.
SBIO shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Nov 6, 2014, and its management style is Passive.
SBIO expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
SBIO follows the NASDAQ / Biotechnology. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
SBIO invests in stocks.
SBIO price has risen by 2.56% over the last month, and its yearly performance shows a −11.17% decrease. See more dynamics on SBIO price chart.
NAV returns, another gauge of an ETF dynamics, showed a −10.69% decrease in three-month performance and has decreased by −12.82% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −10.69% decrease in three-month performance and has decreased by −12.82% in a year.
SBIO trades at a premium (0.36%) meaning the ETF is trading at a higher price than the calculated NAV.